Related Experiment Video
Updated: Dec 2, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.7K
[Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment]
E S Petrakova1, N M Savina2, A V Molochkov1
1Central Clinical Hospital with Out-patient Clinic of the Department of Affairs of the President of the Russian Federation, Moscow.
Kardiologiia
|November 2, 2020
Summary
This review examines atrial fibrillation (AF) after coronary bypass surgery in ischemic heart disease patients. It details risk factors, including diabetes, and discusses current prevention and treatment strategies for postoperative AF.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a common complication after coronary bypass surgery (CABG).
- Ischemic heart disease patients undergoing CABG are at particular risk.
- Postoperative AF can lead to adverse outcomes.
Purpose of the Study:
- To review risk factors for atrial fibrillation following coronary bypass surgery.
- To analyze the impact of diabetes mellitus on the development of postoperative AF.
- To summarize current prevention and treatment strategies for AF in this patient population.
Main Methods:
- Literature review of studies on atrial fibrillation after coronary bypass surgery.
- Analysis of risk factors, with a focus on diabetes mellitus.
- Synthesis of data on AF prevention and treatment modalities.
Main Results:
- Identified key risk factors contributing to postoperative AF.
- Highlighted the significant role of diabetes mellitus in AF development.
- Provided an overview of existing evidence-based prevention and treatment options.
Conclusions:
- Effective management of risk factors is crucial for reducing postoperative AF incidence.
- Diabetes management may play a role in mitigating AF risk post-CABG.
- Further research is needed to optimize AF prevention and treatment protocols.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
243
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
243
01:25Aortic Regurgitation III: Medical Management
202
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
202
01:27Coronary Artery Disease V: Interprofessional Care
145
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
145
01:26Coronary Artery Disease IV: Preventive Measures
497
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
497
01:28Acute Coronary Syndrome IV: Interprofessional Care
123
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
123
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
155
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
155